Cytotoxic flavaglines and bisamides from Aglaia edulis
- PMID: 17190457
- PMCID: PMC2471874
- DOI: 10.1021/np060428x
Cytotoxic flavaglines and bisamides from Aglaia edulis
Erratum in
- J Nat Prod. 2007 Apr;70(4):714
Abstract
Two new cyclopenta[b]benzofurans, aglaroxin A 1-O-acetate (2) and 3'-methoxyaglaroxin A 1-O-acetate (3), a new benzo[b]oxepine, 19,20-dehydroedulisone A (4), and five new cyclopenta[bc]benzopyrans, edulirin A (5), edulirin A 10-O-acetate (6), 19,20-dehydroedulirin A (7), isoedulirin A (8), and edulirin B (9), were isolated from the bark of Aglaia edulis, along with one known cyclopenta[b]benzofuran, aglaroxin A (1). Additionally, four new amides, aglamides A-D (10-13), as well as three known compounds, aglalactone, scopoletin, and 5-hydroxy-3,6,7,4'-tetramethoxyflavone, were isolated from the leaves and/or twigs of this species. The structures of the new compounds (2-13) were elucidated by interpretation of their spectroscopic data. All isolates obtained in this study were evaluated for cytotoxicity against both several human cancer cell lines (Lu1, LNCaP, and MCF-7) and a nontumorigenic (HUVEC) cell line. Among these isolates, the cyclopenta[b]benzofurans (1-3) exhibited potent in vitro cytotoxic activity (ED50 range 0.001 to 0.8 microg/mL). Aglaroxin A 1-O-acetate (2) was further evaluated in the in vivo P388 lymphocytic leukemia model, by intraperitoneal injection, but found to be inactive in this model.
Similar articles
-
Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae).Phytochem Rev. 2022;21(3):725-764. doi: 10.1007/s11101-021-09761-5. Epub 2021 Jun 4. Phytochem Rev. 2022. PMID: 34104125 Free PMC article. Review.
-
Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa.J Nat Prod. 2004 Mar;67(3):343-7. doi: 10.1021/np0304417. J Nat Prod. 2004. PMID: 15043407
-
Cytotoxic cyclopenta[b]benzofuran derivatives from the stem bark of Aglaia formosana.Planta Med. 2001 Aug;67(6):555-7. doi: 10.1055/s-2001-16471. Planta Med. 2001. PMID: 11509980
-
Flavaglines with anti-neuroinflammatory activity from Aglaia edulis (Roxb.) Wall. and structure revision of related flavaglines.Phytochemistry. 2025 Jan;229:114298. doi: 10.1016/j.phytochem.2024.114298. Epub 2024 Oct 16. Phytochemistry. 2025. PMID: 39419315
-
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.Anticancer Agents Med Chem. 2006 Jul;6(4):319-45. doi: 10.2174/187152006777698123. Anticancer Agents Med Chem. 2006. PMID: 16842234 Review.
Cited by
-
Constituents of the Leaves and Stem Bark of Aglaia foveolata.Tetrahedron. 2007 Aug 13;63(33):7926-7934. doi: 10.1016/j.tet.2007.05.074. Tetrahedron. 2007. PMID: 18698338 Free PMC article.
-
A phenolic ester from Aglaia loheri leaves reveals cytotoxicity towards sensitive and multidrug-resistant cancer cells.BMC Complement Altern Med. 2013 Oct 27;13:286. doi: 10.1186/1472-6882-13-286. BMC Complement Altern Med. 2013. PMID: 24160768 Free PMC article.
-
Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae).Phytochem Rev. 2022;21(3):725-764. doi: 10.1007/s11101-021-09761-5. Epub 2021 Jun 4. Phytochem Rev. 2022. PMID: 34104125 Free PMC article. Review.
-
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.Nat Prod Rep. 2014 Jul;31(7):924-39. doi: 10.1039/c4np00006d. Epub 2014 May 2. Nat Prod Rep. 2014. PMID: 24788392 Free PMC article. Review.
-
Silacyclization through palladium-catalyzed intermolecular silicon-based C(sp2)-C(sp3) cross-coupling.Chem Sci. 2021 Oct 7;12(42):14224-14229. doi: 10.1039/d1sc04180k. eCollection 2021 Nov 3. Chem Sci. 2021. PMID: 34760208 Free PMC article.
References
-
- Proksch P, Edrada R, Ebel R, Bohnenstengel FI, Nugroho BW. Curr Org Chem. 2001;5:923–938.
-
- Kim S, Salim AA, Swanson SM, Kinghorn AD. Anti-cancer Agents Med Chem. 2006;6:319–345. - PubMed
-
- Brader G, Vajrodaya S, Greger H, Bacher M, Kalchhauser H, Hofer O. J Nat Prod. 1998;61:1482–1490. - PubMed
-
- Nugroho BW, Edrada RA, Wray V, Witte L, Bringmann G, Gehling M, Proksch P. Phytochemistry. 1999;51:367–376.
-
- Bacher M, Hofer O, Brader G, Vajrodaya S, Greger H. Phytochemistry. 1999;52:253–263.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
